Blood 2018 Sep 6
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Related Questions
Have the RAPID or CALGB 5064 studies changed your treatment approach?
New answer by Medical Oncologist at Long Island Jewish Medical Center (January 30, 2021)
4 cycles without radiation therapy.